Abstract:
A double-clad optical fiber includes a core, an inner cladding and an outer cladding of silica-based glass. The core may have a radius of less than about 5 μm, a first index of refraction n1 and does not contain any active rare-earth dopants. The inner cladding may surround the core and includes a radial thickness of at least about 25 μm, a numerical aperture of at least about 0.25, and a second index of refraction n2 such that n2
Abstract:
A switchable resistive device has a multi-layer thin film structure interposed between an upper conductive electrode and a lower conductive electrode. The multi-layer thin film structure comprises a perovskite layer with one buffer layer on one side of the perovskite layer, or a perovskite layer with buffer layers on both sides of the perovskite layer. Reversible resistance changes are induced in the device under applied electrical pulses. The resistance changes of the device are retained after applied electric pulses. The functions of the buffer layer(s) added to the device include magnification of the resistance switching region, reduction of the pulse voltage needed to switch the device, protection of the device from being damaged by a large pulse shock, improvement of the temperature and radiation properties, and increased stability of the device allowing for multivalued memory applications.
Abstract:
Substituted phenylacetic acids, phenylethanols and related compounds are provided that are useful in treating or controlling a number of diseases associated with glucose metabolism, lipid metabolism and insulin secretion.
Abstract:
Compounds, compositions, and methods relating to 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof are provided for the treatment of Type II diabetes and other diseases associated with poor glycemic control.
Abstract:
2-Aminopyridine compounds having the structure of Formula I, and pharmaceutically acceptable salts of these compounds. Compounds of Formula I inhibit the activity of tyrosine kinase enzymes in animals, including humans, and are useful in the treatment and/or prevention of various diseases and conditions. In particular, compounds disclosed herein are inhibitors of kinases, in particular, but not limited to, KDR, Tie-2, Flt3, FGFR3, Ab1, Aurora A, c-Src, IGF-1R, ALK, c-MET, RON, PAK1, PAK2, and TAK1, and can be used in the treatment of proliferative diseases, such as, but not limited to, cancer. The present invention is also directed to a pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The present invention is further directed to a method of treating a patient having a condition which is mediated by protein kinase activity by administering to the patient a therapeutically effective amount of the above-mentioned pharmaceutical composition.
Abstract:
Disclosed are a system and method for identifying objects in an image dataset that occlude other objects and for transforming the image dataset to reveal the occluded objects. In some cases, occluding objects are identified by processing the image dataset to determine the relative positions of visual objects. Occluded objects are then revealed by removing the occluding objects from the image dataset or by otherwise de-emphasizing the occluding objects so that the occluded objects are seen behind it. A visual object may be removed simply because it occludes another object, because of privacy concerns, or because it is transient. When an object is removed or de-emphasized, the objects that were behind it may need to be “cleaned up” so that they show up well. To do this, information from multiple images can be processed using interpolation techniques. The image dataset can be further transformed by adding objects to the images.
Abstract:
An optical fiber comprising: a glass core extending from a centerline to a radius R1; a glass cladding surrounding and in contact with the core, the cladding comprising:a first annular region extending from R1 to a radius R2, the first annular region comprising a radial width, W2=R2−R1, a second annular region extending from R2 to a radius R3, the second annular region comprising a radial width, W3=R3−R2, and a third annular region extending from R3 to an outermost glass radius R4; wherein (i) the core comprises a maximum relative refractive index, Δ1MAX, relative to the third annular region; (ii) wherein the first annular region comprises a radial width W2; and (iii) the second annular region comprises a minimum relative refractive index, Δ3MIN, relative to the third annular region wherein Δ1MAX>Δ2MAX>Δ3MIN, and Δ2MIN>Δ3MIN; and the core and the cladding provide a fiber with cable cutoff less than 1500 nm, dispersion at 1550 nm less than 12 ps/nm/km, effective area at 1550 nm greater than 60 μm2, and preferably greater than 70 μm2. The second annular cladding region may contain a plurality of randomly dispersed holes.
Abstract:
An optical fiber according to an embodiment of the present invention comprises: a glass core extending from a centerline to a radius R1 wherein R1 is greater than about 5 μm; a glass cladding surrounding and in contact with the core, the cladding comprising: (i) a first annular region extending from the radius R1 to a radius R2, the first annular region comprising a radial width, W2=R2−R1, (ii) a second annular region extending from the radius R2 to a radius R3, and comprising a radial width, W3=R3−R2, and (iii) a third annular region surrounding the second annular region and extending from the radius R3 to an outermost glass radius R4; wherein the core comprises a maximum relative refractive index, Δ1MAX, relative to the third annular region, and wherein Δ1MAX is greater than about 0.1% and less than about 0.3%; the first annular region has a refractive index delta Δ2(r) is less than about 0.025%; wherein the second annular region comprises a minimum relative refractive index, Δ3MIN, relative to the third annular region;wherein Δ1MAX>Δ2MAX>Δ3MIN, and Δ2MIN>Δ3MIN
Abstract:
The present invention provides a methods and compounds for producing an enantiomerically enriched α-(phenoxy)phenylacetic acid compound of the formula: from a mixture of its enantiomers, where R1 is alkyl or haloalkyl and X is halide.
Abstract:
An optical fiber comprising: (i) a silica based passive core having a first index of refraction n1; (ii) a silica based cladding surrounding the core and having a second index of refraction n2, such that n1>n2, said cladding having at least one stress rod and at least one air hole extending longitudinally through the length of said optical fiber; and (iii) wherein said optical fiber supports a single polarization mode or poses polarization maintaining properties within the operating wavelength range.